These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1746 related articles for article (PubMed ID: 26195256)

  • 1. Clearance systems in the brain-implications for Alzheimer disease.
    Tarasoff-Conway JM; Carare RO; Osorio RS; Glodzik L; Butler T; Fieremans E; Axel L; Rusinek H; Nicholson C; Zlokovic BV; Frangione B; Blennow K; Ménard J; Zetterberg H; Wisniewski T; de Leon MJ
    Nat Rev Neurol; 2015 Aug; 11(8):457-70. PubMed ID: 26195256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.
    Xin SH; Tan L; Cao X; Yu JT; Tan L
    Neurotox Res; 2018 Oct; 34(3):733-748. PubMed ID: 29626319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome.
    Oddo S; Billings L; Kesslak JP; Cribbs DH; LaFerla FM
    Neuron; 2004 Aug; 43(3):321-32. PubMed ID: 15294141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease.
    Chachaj A; Gąsiorowski K; Szuba A; Sieradzki A; Leszek J
    Curr Neuropharmacol; 2023; 21(2):380-391. PubMed ID: 35410605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.
    Cheng Y; Tian DY; Wang YJ
    Transl Neurodegener; 2020 May; 9(1):16. PubMed ID: 32381118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connections Between Amyloid Beta and the Meningeal Lymphatics As a Possible Route for Clearance and Therapeutics.
    Dupont G; Iwanaga J; Yilmaz E; Tubbs RS
    Lymphat Res Biol; 2020 Feb; 18(1):2-6. PubMed ID: 31433264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.
    Peng W; Achariyar TM; Li B; Liao Y; Mestre H; Hitomi E; Regan S; Kasper T; Peng S; Ding F; Benveniste H; Nedergaard M; Deane R
    Neurobiol Dis; 2016 Sep; 93():215-25. PubMed ID: 27234656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.
    Loeffler DA
    J Alzheimers Dis; 2024; 100(2):379-411. PubMed ID: 38875041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the glymphatic/meningeal lymphatic system in Alzheimer's disease: insights into proteostasis and future directions.
    Yamada K; Iwatsubo T
    Cell Mol Life Sci; 2024 Apr; 81(1):192. PubMed ID: 38652179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions.
    Ueno M; Chiba Y; Murakami R; Matsumoto K; Kawauchi M; Fujihara R
    Brain Tumor Pathol; 2016 Apr; 33(2):89-96. PubMed ID: 26920424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.
    Zuroff L; Daley D; Black KL; Koronyo-Hamaoui M
    Cell Mol Life Sci; 2017 Jun; 74(12):2167-2201. PubMed ID: 28197669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease.
    Alvira-Botero X; Carro EM
    Curr Aging Sci; 2010 Dec; 3(3):219-29. PubMed ID: 20735345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between blood-brain barrier and glymphatic system in solute clearance.
    Verheggen ICM; Van Boxtel MPJ; Verhey FRJ; Jansen JFA; Backes WH
    Neurosci Biobehav Rev; 2018 Jul; 90():26-33. PubMed ID: 29608988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
    Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
    J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease.
    Li Y; Zhang J; Wan J; Liu A; Sun J
    Biomed Pharmacother; 2020 Dec; 132():110887. PubMed ID: 33254429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain.
    Duarte AC; Hrynchak MV; Gonçalves I; Quintela T; Santos CR
    J Neuroendocrinol; 2016 Nov; 28(11):. PubMed ID: 27632792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.